Detalles de la búsqueda
1.
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Blood
; 142(1): 73-89, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37018663
2.
Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Lipids Health Dis
; 22(1): 97, 2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37420217
3.
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Am J Hematol
; 97(4): 421-430, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015312
4.
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
Br J Haematol
; 193(5): 915-921, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33782950
5.
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.
Eur J Haematol
; 107(6): 617-623, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418168
6.
Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(1): 50-57, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31525494
7.
KIT signaling is dispensable for human mast cell progenitor development.
Blood
; 130(16): 1785-1794, 2017 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28790106
8.
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.
Blood
; 129(17): 2384-2394, 2017 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28122740
9.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
Am J Hematol
; 94(11): 1236-1243, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31456269
10.
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Lancet Oncol
; 19(6): 747-757, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735299
11.
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
Eur J Haematol
; 98(1): 57-66, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27428357
12.
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.
Ann Intern Med
; 165(3): 161-6, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27295519
13.
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Eur J Haematol
; 97(4): 387-92, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833713
14.
In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia.
Ther Drug Monit
; 38(2): 230-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26693810
15.
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Br J Haematol
; 169(5): 683-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817799
16.
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
Blood
; 122(7): 1284-92, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23843494
17.
Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
BMC Cancer
; 15: 45, 2015 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25880391
18.
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).
Eur J Haematol
; 94(3): 243-50, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25082346
19.
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.
Leukemia
; 38(1): 109-125, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919606
20.
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Leukemia
; 38(4): 781-787, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278960